Opioid facilitation of ß-adrenergic blockade: A new pharmacological condition?

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Recently, propranolol was suggested to prevent hyperlactatemia in a child with hypovolemic shock through ß-adrenergic blockade. Though it is a known inhibitor of glycolysis, propranolol, outside this observation, has never been reported to fully protect against lactate overproduction. On the other hand, literature evidence exists for a cross-talk between ß-adrenergic receptors (protein targets of propranolol) and δ-opioid receptor. In this literature context, it is hypothesized here that anti-diarrheic racecadotril (a pro-drug of thiorphan, an inhibitor of enkephalinases), which, in the cited observation, was co-administered with propranolol, might have facilitated the ß-blocker-driven inhibition of glycolysis and resulting lactate production. The opioid-facilitated ß-adrenergic blockade would be essentially additivity or even synergism putatively existing between antagonism of δ-adrenergic receptors and agonism of d-opioid receptor in lowering cellular cAMP and dependent functions.

Cite

CITATION STYLE

APA

Vamecq, J., Mention-Mulliez, K., Leclerc, F., & Dobbelaere, D. (2015). Opioid facilitation of ß-adrenergic blockade: A new pharmacological condition? Pharmaceuticals, 8(4), 664–674. https://doi.org/10.3390/ph8040664

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free